Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BD Drugs for urinary frequency and incontinence
G04BD14 Imidafenacin
D06273 Imidafenacin (JAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
25 Urogenital and anal organ agents
259 Miscellaneous
2590 Miscellaneous
D06273 Imidafenacin (JAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
D06273 Imidafenacin
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D06273 Imidafenacin
DG02924 UGT substrate
DG03182 UGT1A4 substrate
D06273 Imidafenacin
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM1
D06273 Imidafenacin (JAN/INN) <JP>
CHRM3
D06273 Imidafenacin (JAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D06273
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D06273
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D06273